{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:13:50Z","timestamp":1777468430044,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lupus nephritis (LN) is the most common and serious complication of systemic lupus erythematosus (SLE). LN pathogenesis is not fully understood. Axl receptor tyrosine kinase is upregulated and contributes to the pathogenic progress in LN. We have reported that Axl disruption attenuates nephritis development in mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we analyzed the gene expression profiles with RNA-seq using renal cortical samples from nephritic mice. Axl-KO mice were bred onto a B6.lpr spontaneous lupus background, and renal disease development was followed and compared to the Axl-sufficient B6.lpr mice. Finally, anti-glomerular basement membrane (anti-GBM) Ab-induced nephritic mice were treated with Axl small molecule inhibitor, R428, at different stages of nephritis development. Blood urine nitrogen levels and renal pathologies were evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Transcriptome analysis revealed that renal Axl activation contributed to cell proliferation, survival, and motility through regulation of the Akt, c-Jun, and actin pathways. Spontaneous lupus-prone B6.lpr mice with Axl deficiency showed significantly reduced kidney damages and decreased T cell infiltration compared to the renal damage and T cell infiltration in Axl-sufficient B6.lpr mice. The improved kidney function was independent of autoAb production. Moreover, R428 significantly reduced anti-GBM glomerulonephritis at different stages of GN development compared to the untreated nephritic control mice. R428 administration reduced inflammatory cytokine (IL-6) production, T cell infiltration, and nephritis disease activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Results from this study emphasize the important role of Axl signaling in LN and highlight Axl as an attractive target in LN.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-022-02965-w","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T08:03:14Z","timestamp":1672214594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Axl regulated survival\/proliferation network and its therapeutic intervention in mouse models of glomerulonephritis"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuxuan","family":"Zhen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Medvedovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"key":"2965_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","volume":"6","author":"HJ Anders","year":"2020","unstructured":"Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020;6:7.","journal-title":"Nat Rev Dis Primers"},{"key":"2965_CR2","first-page":"468","volume":"18","author":"A Davidson","year":"2006","unstructured":"Davidson A, Aranow C. Pathogenesis and treatment of systemic lupus erythematosus nephritis. Curr Opin Rheumatol. 2006;18:468\u201375.","journal-title":"Curr Opin Rheumatol"},{"key":"2965_CR3","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10067-019-04467-8","volume":"38","author":"SY Chen","year":"2019","unstructured":"Chen SY, Liu MF, Kuo PY, Wang CR. Upregulated expression of STAT3\/IL-17 in patients with systemic lupus erythematosus. Clin Rheumatol. 2019;38:1361\u20136.","journal-title":"Clin Rheumatol"},{"key":"2965_CR4","doi-asserted-by":"publisher","first-page":"271694","DOI":"10.1155\/2011\/271694","volume":"2011","author":"D Perry","year":"2011","unstructured":"Perry D, Sang A, Yin Y, Zheng YY, Morel L. Murine models of systemic lupus erythematosus. J Biomed Biotechnol. 2011;2011:271694.","journal-title":"J Biomed Biotechnol"},{"key":"2965_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/cei.13147","volume":"193","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Yue Y, Xiong S. Administration of activated lymphocyte-derived DNA accelerates and aggravates lupus nephritis in B6\/lpr mice: a new approach to modify a lupus murine model. Clin Exp Immunol. 2018;193:302\u201312.","journal-title":"Clin Exp Immunol"},{"key":"2965_CR6","doi-asserted-by":"publisher","first-page":"e000199","DOI":"10.1136\/lupus-2016-000199","volume":"5","author":"ML Richard","year":"2018","unstructured":"Richard ML, Gilkeson G. Mouse models of lupus: what they tell us and what they don\u2019t. Lupus Sci Med. 2018;5:e000199.","journal-title":"Lupus Sci Med"},{"key":"2965_CR7","doi-asserted-by":"publisher","first-page":"a009076","DOI":"10.1101\/cshperspect.a009076","volume":"5","author":"G Lemke","year":"2013","unstructured":"Lemke G. Biology of the TAM receptors. Cold Spring Harb Perspect Biol. 2013;5:a009076.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2965_CR8","first-page":"2349","volume":"10","author":"DK Graham","year":"1995","unstructured":"Graham DK, Bowman GW, Dawson TL, Stanford WL, Earp HS, Snodgrass HR. Cloning and developmental expression analysis of the murine c-mer tyrosine kinase. Oncogene. 1995;10:2349\u201359.","journal-title":"Oncogene"},{"key":"2965_CR9","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1158\/1078-0432.CCR-08-2514","volume":"15","author":"A Gustafsson","year":"2009","unstructured":"Gustafsson A, Martuszewska D, Johansson M, Ekman C, Hafizi S, Ljungberg B, Dahlback B. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival. Clin Cancer Res. 2009;15:4742\u20139.","journal-title":"Clin Cancer Res"},{"key":"2965_CR10","doi-asserted-by":"publisher","first-page":"e0232055","DOI":"10.1371\/journal.pone.0232055","volume":"15","author":"A Kurata","year":"2020","unstructured":"Kurata A, Tachibana Y, Takahashi T, Horiba N. Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells. PLoS One. 2020;15:e0232055.","journal-title":"PLoS One"},{"issue":"3","key":"2965_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/JLB.2A1220-850RRR","volume":"111","author":"Y Zhen","year":"2022","unstructured":"Zhen Y, McGaha TL, Finkelman FD, Shao WH. The Akt-mTORC1 pathway mediates Axl receptor tyrosine kinase-induced mesangial cell proliferation. J Leukoc Biol. 2022;111(3):563\u201371.","journal-title":"J Leukoc Biol."},{"key":"2965_CR12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1053\/j.ajkd.2003.10.016","volume":"43","author":"A Fiebeler","year":"2004","unstructured":"Fiebeler A, Park JK, Muller DN, Lindschau C, Mengel M, Merkel S, Banas B, Luft FC, Haller H. Growth arrest specific protein 6\/Axl signaling in human inflammatory renal diseases. Am J Kidney Dis. 2004;43:286\u201395.","journal-title":"Am J Kidney Dis"},{"key":"2965_CR13","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1093\/ndt\/gfs337","volume":"27","author":"IJ Lee","year":"2012","unstructured":"Lee IJ, Hilliard B, Swami A, Madara JC, Rao S, Patel T, Gaughan JP, Lee J, Gadegbeku CA, Choi ET, Cohen PL. Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure. Nephrol Dial Transplant. 2012;27:4166\u201372.","journal-title":"Nephrol Dial Transplant"},{"key":"2965_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jaut.2018.06.001","volume":"93","author":"Y Zhen","year":"2018","unstructured":"Zhen Y, Lee IJ, Finkelman FD, Shao WH. Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis. J Autoimmun. 2018;93:37\u201344.","journal-title":"J Autoimmun"},{"key":"2965_CR15","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.4049\/jimmunol.1600793","volume":"197","author":"Y Zhen","year":"2016","unstructured":"Zhen Y, Priest SO, Shao WH. Opposing roles of tyrosine kinase receptors Mer and Axl determine clinical outcomes in experimental immune-mediated nephritis. J Immunol. 2016;197:2187\u201394.","journal-title":"J Immunol"},{"key":"2965_CR16","doi-asserted-by":"publisher","first-page":"e0212068","DOI":"10.1371\/journal.pone.0212068","volume":"14","author":"I Parodis","year":"2019","unstructured":"Parodis I, Ding H, Zickert A, Cosson G, Fathima M, Gronwall C, Mohan C, Gunnarsson I. Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis. PLoS One. 2019;14:e0212068.","journal-title":"PLoS One"},{"key":"2965_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1172\/JCI0214861","volume":"110","author":"M Yanagita","year":"2002","unstructured":"Yanagita M, Ishimoto Y, Arai H, Nagai K, Ito T, Nakano T, Salant DJ, Fukatsu A, Doi T, Kita T. Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J Clin Invest. 2002;110:239\u201346.","journal-title":"J Clin Invest"},{"key":"2965_CR18","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1681\/ASN.V10122503","volume":"10","author":"M Yanagita","year":"1999","unstructured":"Yanagita M, Ishii K, Ozaki H, Arai H, Nakano T, Ohashi K, Mizuno K, Kita T, Doi T. Mechanism of inhibitory effect of warfarin on mesangial cell proliferation. J Am Soc Nephrol. 1999;10:2503\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"2965_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, D\u2019Agati VD, Ferrario F, Haas M, Jennette JC, Joh K, Nast CC, Noel LH, Rijnink EC, Roberts ISD, Seshan SV, Sethi S, Fogo AB. Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 2018;93:789\u201396.","journal-title":"Kidney Int"},{"key":"2965_CR20","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.4049\/jimmunol.180.11.7728","volume":"180","author":"WH Shao","year":"2008","unstructured":"Shao WH, Eisenberg RA, Cohen PL. The Mer receptor tyrosine kinase is required for the loss of B cell tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus. J Immunol. 2008;180:7728\u201335.","journal-title":"J Immunol"},{"key":"2965_CR21","doi-asserted-by":"crossref","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S. STAR: ultrafast universal RNA-seq aligner. Bioinformatics.\u00a02013;29(1):15\u201321.","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"2965_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2006-7-s1-s4","volume":"7","author":"J Harrow","year":"2006","unstructured":"Harrow J, Denoeud F, Frankish A, Reymond A, Chen C-K, Chrast J, Lagarde J, Gilbert JG, Storey R, Swarbreck D, Rossier C, Ucla C, Hubbard T, Antonarakis SE, Guigo R. GENCODE: producing a reference annotation for ENCODE. Genome Biol. 2006;7:1\u20139.","journal-title":"Genome Biol"},{"key":"2965_CR23","volume-title":"FastQC: a quality control tool for high throughput sequence data","author":"S Andrews","year":"2014","unstructured":"Andrews S. FastQC: a quality control tool for high throughput sequence data. 2014."},{"key":"2965_CR24","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/bioinformatics\/bts196","volume":"28","author":"DS DeLuca","year":"2012","unstructured":"DeLuca DS, Levin JZ, Sivachenko A, Fennell T, Nazaire MD, Williams C, Reich M, Winckler W, Getz G. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics. 2012;28:1530\u20132.","journal-title":"Bioinformatics"},{"key":"2965_CR25","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, Magnusson M, Lundin S, K\u00e4ller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32:3047\u20138.","journal-title":"Bioinformatics"},{"key":"2965_CR26","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA. 2003;100:9440\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2965_CR27","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/nprot.2013.099","volume":"8","author":"S Anders","year":"2013","unstructured":"Anders S, McCarthy DJ, Chen Y, Okoniewski M, Smyth GK, Huber W, Robinson MD. Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat Protocols. 2013;8:1765\u201386.","journal-title":"Nat Protocols"},{"key":"2965_CR28","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/bioinformatics\/18.9.1194","volume":"18","author":"M Medvedovic","year":"2002","unstructured":"Medvedovic M, Sivaganesan S. Bayesian infinite mixture model based clustering of gene expression profiles. Bioinformatics. 2002;18:1194\u2013206.","journal-title":"Bioinformatics"},{"key":"2965_CR29","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1093\/bioinformatics\/bth068","volume":"20","author":"M Medvedovic","year":"2004","unstructured":"Medvedovic M, Yeung KY, Bumgarner RE. Bayesian mixture model based clustering of replicated microarray data. Bioinformatics. 2004;20:1222\u201332.","journal-title":"Bioinformatics"},{"key":"2965_CR30","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/bioinformatics\/btl184","volume":"22","author":"X Liu","year":"2006","unstructured":"Liu X, Sivaganesan S, Yeung KY, Guo J, Bumgarner RE, Medvedovic M. Context-specific infinite mixtures for clustering gene expression profiles across diverse microarray dataset. Bioinformatics. 2006;22:1737\u201344.","journal-title":"Bioinformatics"},{"key":"2965_CR31","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/1471-2105-11-234","volume":"11","author":"JM Freudenberg","year":"2010","unstructured":"Freudenberg JM, Sivaganesan S, Wagner M, Medvedovic M. A semi-parametric Bayesian model for unsupervised differential co-expression analysis. BMC Bioinformatics. 2010;11:234.","journal-title":"BMC Bioinformatics"},{"key":"2965_CR32","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2965_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fphys.2013.00278","volume":"4","author":"C Mitrea","year":"2013","unstructured":"Mitrea C, Taghavi Z, Bokanizad B, Hanoudi S, Tagett R, Donato M, Voichita C, Draghici S. Methods and approaches in the topology-based analysis of biological pathways. Front Physiol. 2013;4:278.","journal-title":"Front Physiol"},{"key":"2965_CR34","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353\u201361.","journal-title":"Nucleic Acids Res"},{"key":"2965_CR35","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo W, Brouwer C. Pathview: an R\/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29:1830\u20131.","journal-title":"Bioinformatics"},{"key":"2965_CR36","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.4049\/jimmunol.0903595","volume":"184","author":"VC Kyttaris","year":"2010","unstructured":"Kyttaris VC, Zhang Z, Kuchroo VK, Oukka M, Tsokos GC. Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL\/6-lpr\/lpr mice. J Immunol. 2010;184:4605\u20139.","journal-title":"J Immunol"},{"key":"2965_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41584-020-0401-9","volume":"16","author":"NI Maria","year":"2020","unstructured":"Maria NI, Davidson A. Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy. Nat Rev Rheumatol. 2020;16:255\u201367.","journal-title":"Nat Rev Rheumatol"},{"key":"2965_CR38","doi-asserted-by":"crossref","unstructured":"Davidson, A. 2015. What is damaging the kidney in lupus nephritis?. Nat Rev Rheumatol.","DOI":"10.1038\/nrrheum.2015.159"},{"key":"2965_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000431278","volume":"1","author":"L Bao","year":"2015","unstructured":"Bao L, Cunningham PN, Quigg RJ. Complement in lupus nephritis: new perspectives. Kidney Dis (Basel). 2015;1:91\u20139.","journal-title":"Kidney Dis (Basel)"},{"key":"2965_CR40","doi-asserted-by":"publisher","first-page":"42364","DOI":"10.1074\/jbc.M107488200","volume":"276","author":"M Yanagita","year":"2001","unstructured":"Yanagita M, Arai H, Nakano T, Ohashi K, Mizuno K, Fukatsu A, Doi T, Kita T. Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. J Biol Chem. 2001;276:42364\u20139.","journal-title":"J Biol Chem"},{"key":"2965_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.semnephrol.2006.09.007","volume":"27","author":"MH Foster","year":"2007","unstructured":"Foster MH. T cells and B cells in lupus nephritis. Semin Nephrol. 2007;27:47\u201358.","journal-title":"Semin Nephrol"},{"key":"2965_CR42","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.4049\/jimmunol.0901301","volume":"183","author":"MA Otten","year":"2009","unstructured":"Otten MA, Groeneveld TW, Flierman R, Rastaldi MP, Trouw LA, Faber-Krol MC, Visser A, Essers MC, Claassens J, Verbeek JS, van Kooten C, Roos A, Daha MR. Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in mice. J Immunol. 2009;183:3980\u20138.","journal-title":"J Immunol"},{"key":"2965_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ki.1990.171","volume":"38","author":"G Schrijver","year":"1990","unstructured":"Schrijver G, Bogman MJ, Assmann KJ, de Waal RM, Robben HC, van Gasteren H, Koene RA. Anti-GBM nephritis in the mouse: role of granulocytes in the heterologous phase. Kidney Int. 1990;38:86\u201395.","journal-title":"Kidney Int"},{"key":"2965_CR44","first-page":"126","volume":"2","author":"WG Couser","year":"1982","unstructured":"Couser WG, Salant DJ, Madaio MP, Adler S, Groggel GC. Factors influencing glomerular and tubulointerstitial patterns of injury in SLE. Am J Kidney Dis. 1982;2:126\u201334.","journal-title":"Am J Kidney Dis"},{"key":"2965_CR45","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1191\/0961203304lu1023oa","volume":"13","author":"E Tackey","year":"2004","unstructured":"Tackey E, Lipsky PE, Illei GG. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus. 2004;13:339\u201343.","journal-title":"Lupus"},{"key":"2965_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","volume":"8","author":"H Su","year":"2017","unstructured":"Su H, Lei CT, Zhang C. Interleukin-6 signaling pathway and its role in kidney disease: an update. Front Immunol. 2017;8:405.","journal-title":"Front Immunol"},{"key":"2965_CR47","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.clim.2010.04.002","volume":"136","author":"WH Shao","year":"2010","unstructured":"Shao WH, Zhen Y, Rosenbaum J, Eisenberg RA, McGaha TL, Birkenbach M, Cohen PL. A protective role of Mer receptor tyrosine kinase in nephrotoxic serum-induced nephritis. Clin Immunol. 2010;136:236\u201344.","journal-title":"Clin Immunol"},{"key":"2965_CR48","doi-asserted-by":"publisher","first-page":"8818","DOI":"10.18632\/oncotarget.2422","volume":"5","author":"H Axelrod","year":"2014","unstructured":"Axelrod H, Pienta KJ. Axl as a mediator of cellular growth and survival. Oncotarget. 2014;5:8818\u201352.","journal-title":"Oncotarget"},{"key":"2965_CR49","doi-asserted-by":"publisher","first-page":"12753","DOI":"10.18632\/oncotarget.2648","volume":"5","author":"ED Fleuren","year":"2014","unstructured":"Fleuren ED, Hillebrandt-Roeffen MH, Flucke UE, Te Loo DM, Boerman OC, van der Graaf WT, Versleijen-Jonkers YM. The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma. Oncotarget. 2014;5:12753\u201368.","journal-title":"Oncotarget"},{"key":"2965_CR50","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1158\/0008-5472.CAN-09-2997","volume":"70","author":"SJ Holland","year":"2010","unstructured":"Holland SJ, Pan A, Franci C, Hu Y, Chang B, Li W, Duan M, Torneros A, Yu J, Heckrodt TJ, Zhang J, Ding P, Apatira A, Chua J, Brandt R, Pine P, Goff D, Singh R, Payan DG, Hitoshi Y. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res. 2010;70:1544\u201354.","journal-title":"Cancer Res"},{"key":"2965_CR51","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0002-9440(10)64093-X","volume":"158","author":"M Yanagita","year":"2001","unstructured":"Yanagita M, Arai H, Ishii K, Nakano T, Ohashi K, Mizuno K, Varnum B, Fukatsu A, Doi T, Kita T. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am J Pathol. 2001;158:1423\u201332.","journal-title":"Am J Pathol"},{"key":"2965_CR52","doi-asserted-by":"crossref","unstructured":"Badarni, M., M. Prasad, N. Balaban, J. Zorea, K. M. Yegodayev, B. Z. Joshua, A. B. Dinur, R. Grenman, B. Rotblat, L. Cohen, and M. Elkabets. 2019. Repression of AXL expression by AP-1\/JNK blockage overcomes resistance to PI3Ka therapy. JCI Insight. 5.","DOI":"10.1172\/jci.insight.125341"},{"key":"2965_CR53","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1172\/JCI120859","volume":"128","author":"JS Tilstra","year":"2018","unstructured":"Tilstra JS, Avery L, Menk AV, Gordon RA, Smita S, Kane LP, Chikina M, Delgoffe GM, Shlomchik MJ. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J Clin Invest. 2018;128:4884\u201397.","journal-title":"J Clin Invest"},{"key":"2965_CR54","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4049\/jimmunol.176.1.632","volume":"176","author":"Y Fu","year":"2006","unstructured":"Fu Y, Xie C, Chen J, Zhu J, Zhou H, Thomas J, Zhou XJ, Mohan C. Innate stimuli accentuate end-organ damage by nephrotoxic antibodies via Fc receptor and TLR stimulation and IL-1\/TNF-alpha production. J Immunol. 2006;176:632\u20139.","journal-title":"J Immunol"},{"key":"2965_CR55","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1007\/s11427-016-5030-9","volume":"59","author":"SY Hu","year":"2016","unstructured":"Hu SY, Jia XY, Li JN, Zheng X, Ao J, Liu G, Cui Z, Zhao MH. T cell infiltration is associated with kidney injury in patients with anti-glomerular basement membrane disease. Sci China Life Sci. 2016;59:1282\u20139.","journal-title":"Sci China Life Sci"},{"key":"2965_CR56","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/00024382-200014030-00025","volume":"14","author":"ES Hungness","year":"2000","unstructured":"Hungness ES, Pritts TA, Luo GJ, Sun X, Penner CG, Hasselgren PO. The transcription factor activator protein-1 is activated and interleukin-6 production is increased in interleukin-1beta-stimulated human enterocytes. Shock. 2000;14:386\u201391.","journal-title":"Shock"},{"key":"2965_CR57","doi-asserted-by":"publisher","first-page":"e0227187","DOI":"10.1371\/journal.pone.0227187","volume":"15","author":"K Flem-Karlsen","year":"2020","unstructured":"Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Florenes VA, Maelandsmo GM. Soluble AXL as a marker of disease progression and survival in melanoma. PLoS One. 2020;15:e0227187.","journal-title":"PLoS One"},{"key":"2965_CR58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.55563\/clinexprheumatol\/xyylza","volume":"39","author":"M Bellan","year":"2021","unstructured":"Bellan M, Quaglia M, Nerviani A, Mauro D, Lewis M, Goegan F, Gibbin A, Pagani S, Salmi L, Molinari L, Castello LM, Avanzi GC, Cantaluppi V, Pirisi M, Sainaghi PP, Pitzalis C. Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis. Clin Exp Rheumatol. 2021;39:132\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"2965_CR59","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1172\/JCI73531","volume":"124","author":"M Rokavec","year":"2014","unstructured":"Rokavec M, Oner MG, Li H, Jackstadt R, Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, Slotta-Huspenina J, Bader FG, Greten FR, Hermeking H. IL-6R\/STAT3\/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest. 2014;124:1853\u201367.","journal-title":"J Clin Invest"},{"key":"2965_CR60","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1038\/onc.2011.13","volume":"30","author":"G Mudduluru","year":"2011","unstructured":"Mudduluru G, Ceppi P, Kumarswamy R, Scagliotti GV, Papotti M, Allgayer H. Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a\/b in solid cancer. Oncogene. 2011;30:2888\u201399.","journal-title":"Oncogene"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02965-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02965-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02965-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T12:03:11Z","timestamp":1672488191000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02965-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2965"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02965-w","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"284"}}